Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.99 USD | -5.67% | -14.19% | -7.85% |
May. 17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
May. 02 | Transcript : Puma Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.85% | 204M | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- PBYI Stock
- News Puma Biotechnology, Inc.
- Puma Biotechnology : RBC Cuts PT on Puma Biotechnology to $6 From $13, Citing Nerlynx 2021 Sales Estimates; Sector Perform-Speculative Risk Rating Kept